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Short report
Long-term outcomes of trauma-focused
treatment in psychosis
David van den Berg, Paul A. J. M. de Bont, Berber M. van der Vleugel, Carlijn de Roos, Ad de Jongh,
Agnes van Minnen and Mark van der Gaag
Summary
Wepresent 12-month follow-up results for a randomisedcontrolled
trial of prolonged exposure and eyemovement desensitisation and
reprocessing (EMDR) therapy in 85 (78.8%) participants with
psychotic disorder and comorbid post-traumatic stress disorder
(PTSD). Positive effects on clinician-rated PTSD, self-rated PTSD,
depression, paranoid-referential thinking and remission from
schizophrenia were maintained up to 12-month follow-up.
Negativepost-traumatic cognitions declined in prolongedexposure
and were stable in EMDR. A significant decline in social functioning
was found, whereas reductions in interference of PTSD symptoms
with social functioningweremaintained. These results support that
current PTSD guidelines apply to individuals with psychosis.
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The importance of both trauma and post-traumatic stress disorder
(PTSD) in psychosis are increasingly acknowledged. The available
data suggest that trauma-focused treatments (TFTs) with direct
trauma memory processing are particularly effective in reducing
PTSD symptoms in patients with psychosis.1–3 A large randomised
controlled trial (RCT) found TFT to be effective and safe in patients
with both psychosis and PTSD.4,5 Furthermore, TFT had neutral to
positive effects on symptoms of psychosis, depression and social func-
tioning.6 In this RCT, two different TFTs, prolonged exposure therapy
and eye movement desensitisation and reprocessing therapy (EMDR),
were compared with waiting list for TFT at baseline, post-treatment,
and at 6-month follow-up. Compared with the waiting list for TFT,
both prolonged exposure and EMDR significantly decreased clin-
ician-rated PTSD symptoms, self-rated PTSD symptoms, negative
post-traumatic cognitions and paranoid-referential thinking. In both
TFT conditions, significantly more participants achieved remission
from schizophrenia. Only prolonged exposure was found to signifi-
cantly reduce the severity of depression symptoms. In comparison
to the waiting list for TFT, there were no significant effects for pro-
longed exposure and EMDR on social functioning and voice
hearing. Effects observed at post-treatment were generally maintained
until 6-month follow-up. In this short report, we present the 12-
month follow-up outcomes for prolonged exposure and EMDR on
PTSD, depression, social functioning and psychosis.
Method
In this single-blind RCT with three arms, participants (n = 155) that
met both criteria for a lifetime psychotic disorder (61.3% schizophre-
nia and 29.0% schizoaffective disorder) and full criteria for PTSD
received eight sessions of TFT (i.e. prolonged exposure or EMDR),
or remained on the waiting list for TFT. All participants received treat-
ment-as-usual for psychosis. Participants in the waiting list condition
received their TFT of choice after the 6-month follow-up assessment,
since we considered it unethical to withhold treatment for longer than
6 months. The prolonged exposure and EMDR groups were also
assessed at 12-month follow-up. This trial was set up in accordance
with the Consolidated Standards of Reporting Trials guidelines and
received ethical approval from the medical ethics committee of the
VU University Medical Center in Amsterdam and was registered at
isrctn.com (ISRCTN79584912). See van den Berg et al4 and de Bont
et al7 for full details of the trial. At 12-month follow-up, 43 (81.1%)
participants in the prolonged exposure condition and 42 (76.4%)
participants in the EMDR condition completed all assessments and
were included in the analyses.
For this report, we compared the 12-month follow-up outcomes
for prolonged exposure and EMDR with 6-month outcomes to test
whether the effects endured in the long term. We also tested whether
there were significant differences between prolonged exposure and
EMDRat 12-month follow-up. Continuous outcomes (severity of clin-
ician-rated PTSD,8 self-rated PTSD,9 negative post-traumatic cogni-
tions,10 depression,11 social functioning12 and paranoid thinking13)
were analysed with paired sample t-tests (changes between the 6-
month and 12-month follow-up) and independent sample t-tests (dif-
ferences between prolonged exposure and EMDRat 12-month follow-
up). Total scores for voice hearing (Auditory Hallucinations Rating
Scale) and delusions (Delusions Rating Scale; DRS) on the Psychotic
Symptom Rating Scales (PSYRATS)14 were not normally distributed
because of an excess of zero scores (i.e. participants without active
voices or delusions at a certain time point) and were analysed with
the Wilcoxon signed-rank test and the Mann-Whitney U-test.
Remission from schizophrenia status (dichotomous) on the
Structured Clinical Interview for Symptoms of Remission,15 was ana-
lysed with McNemar’s test and χ2 test for independence. All analyses
were repeated with last-observation-carried-forward (LOCF) as sensi-
tivity analysis. Scientists have to balance the decision of whether to
adjust for multiple testing (to reduce the chance of type 1 errors, but
at the expense of increasing the chance of type 2 errors) on the specific
context and research question (e.g. see work by Rothmann16). In this
study, we primarily wanted to test whether treatment effects endured
in the long term, an effect that is generally observed in RCTs testing
prolonged exposure or EMDR. In this context, we believe type 2
errors are more undesirable than type 1 errors, and therefore did not
adjust for multiple testing.
Results
Supplementary Fig. 1 (available at https://doi.org/10.1192/bjp.2017.
30) presents the mean observed scores. There were no significant
changes in severity of clinician-rated PTSD symptoms in prolonged
exposure (t[42] = 0.59, P = 0.559) or EMDR (t[38] = 0.38, P = 0.707)
between the 6-month and 12-month follow-up, or in self-rated
PTSD symptoms (prolonged exposure: t[43] =−0.66, P = 0.514;
EMDR: t[38] =−0.15, P = 0.879). There were significant further
reductions in severity of post-traumatic cognitions in prolonged
exposure between the 6-month and 12-month follow-up (t[41] =
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2.14, P = 0.038), but not in EMDR (t[38] = 0.36, P = 0.722). No
changes in depression symptoms were observed in prolonged
exposure (t[41] = 0.40, P = 0.689) or EMDR (t[38] = 1.26, P =
0.217). There was a significant decrease in level of social functioning
in both PE (t[41] = 4.31, p < 0.001) and EMDR (t[38] = 2.08, P =
0.044) between the 6-month and 12-month follow-up. There were
no significant changes in severity of paranoid thinking in prolonged
exposure (t[41] =−1.22, P = 0.231) or EMDR (t[38] = 1.35, P =
0.184). For all participants, there were no changes in the Auditory
Hallucinations Rating Scale total score in prolonged exposure
(z =−1.81, P = 0.071) or EMDR (z =−0.54, P = 0.586), or in delu-
sions on the DRS between the 6-month and 12-month follow-up
(prolonged exposure: z =−1.06, P = 0.287; EMDR: z = −0.26, P =
0.794). Also, no changes were found in the number of participants
in remission from schizophrenia in prolonged exposure (P = 0.388)
or EMDR (P = 0.999).
Analyses for differences between prolonged exposure and
EMDR at 12-month follow-up yielded no significant results for
any of the outcome variables. The outcomes of the LOCF sensitivity
analyses were similar to the original results; the only difference was
that, in the LOCF analyses, there was a significant decrease in the
DRS total score in both prolonged exposure (z =−3.36, P = 0.001)
and EMDR (z =−2.43, P = 0.015).
Discussion
Prolonged exposure and EMDR were previously found to be effect-
ive, safe and feasible in patients with psychosis and comorbid PTSD
without the use of stabilising psychotherapeutic interventions.4–6
The present study shows that these effects remained at 12-month
follow-up. More specifically, there were no differences between
the 6-month and 12-month follow-up in clinician-rated PTSD,
self-rated PTSD, depression, paranoid-referential thinking, voice
hearing, delusions or the number of participants in remission
from schizophrenia. Negative post-traumatic cognitions declined
further in prolonged exposure, but not in EMDR. At 12-month
follow-up, there were no differences between prolonged exposure
and EMDR on any of the outcomes. Although replication of our
findings is necessary, these results appear to suggest that TFT
with direct trauma memory processing has long-term neutral to
positive effects on symptoms of PTSD, depression and psychosis.
It is difficult to interpret the observed decline in social function-
ing in the context of clear improvements in symptoms. This is in
contrast to the fact that the presence of PTSD symptoms in psych-
osis has been found to be associated with lower levels of social
functioning.17 Interestingly, there were significant reductions in
interference of PTSD symptoms with social functioning from
baseline to 6-month follow-up on the Clinician-Administered
PTSD Scale (items 20–22) compared with the waiting list for TFT
in both prolonged exposure (t[136] =−2.73, P = 0.007) and
EMDR (t[136] =−3.50, P = 0.001); moreover, these effects
endured throughout the 12-month follow-up (prolonged exposure:
t[42] = 1.39, P = 0.170; EMDR: t[38] =−1.08, P = 0.285). This sug-
gests that, in this severely traumatised sample with severe and
complex (and often neglected) symptom profiles (and problems
in many domains of life), many factors other than PTSD may influ-
ence social functioning. Therefore, interventions on other maintain-
ing factors are probably necessary to support further recovery. It
should also be noted that we used a very short and global assessment
of social functioning, which might limit the reliability and validity.
Similarly, the PSYRATS (the measure used for voice hearing and
delusions) is problematic, since it starts with a dichotomous ques-
tion about the presence of voices or delusions.6 Therefore, future
studies should test the effects of TFT on social functioning and
symptoms of psychosis in everyday life using finer-tuned measures,
e.g. the experience sampling method.18 Longer follow-up periods
are also desirable, but pose ethical problems.
We conclude that TFT has long-term positive effects on symptoms
of PTSD, depression and psychosis in people with severe psychotic dis-
orders, and that there seems to be no reason to exclude individuals with
psychosis from TFT. Although replication of these findings and more
research on the long-term effects on social functioning is required,
these findings provide further support for the notion that the current
guidelines for PTSD also apply to individuals with psychosis.
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